Marshall Wace
CVET

Marshall Wace’s Covetrus, Inc. Common Stock CVET Stock Holding History

Marshall Wace’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-73,175
Closed -$1.53M – 3888
2022
Q3 		$1.53M Buy
73,175
+27,543
+60% +$573K ﹤0.01% 2181
2022
Q2 		$946K Sell
45,632
-211,333
-82% -$3.76M ﹤0.01% 2462
2022
Q1 		$4.31M Buy
256,965
+137,607
+115% +$2.41M 0.01% 1478
2021
Q4 		$2.38M Sell
119,358
-211,119
-64% -$3.97M ﹤0.01% 1930
2021
Q3 		$5.99M Buy
+330,477
New +$7.58M 0.02% 840
2021
Q2 		– Sell
-7,912
Closed -$237K – 3381
2021
Q1 		$237K Buy
+7,912
New +$270K ﹤0.01% 2208
2020
Q2 		– Sell
-17,790
Closed -$145K – 2069
2020
Q1 		$145K Buy
+17,790
New +$203K ﹤0.01% 1253
2019
Q4 		– Sell
-2,797
Closed -$33K – 2190
2019
Q3 		$33K Buy
+2,797
New +$51.8K ﹤0.01% 1551

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Marshall Wace's CVET Position: Q4 2022 in Review

Marshall Wace sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 73,175 shares — an estimated $1.53M sold.

Marshall Wace first reported a position in CVET in Q3 2019 and held it in 8 quarters. The position peaked at $5.99M in Q3 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Marshall Wace reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 73,175 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $1.53M.
  • Marshall Wace first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Marshall Wace's Covetrus, Inc. Common Stock position peaked at $5.99M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.